BioCardia, Inc. (BCDA) Financials
BCDA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 3.7 million | 4.4 million |
| 2023-06-30 | 6.4 million | 4.8 million |
| 2023-03-31 | 7.1 million | 5.2 million |
| 2022-12-31 | 9.8 million | 4.9 million |
BCDA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.4 million | 251000 |
| 2023-06-30 | -3.2 million | 317000 |
| 2023-03-31 | -2.6 million | 278000 |
| 2022-12-31 | -3.0 million | 280000 |
BCDA Net Income
No data available :(
BCDA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 1.8 million | - | 1.4 million |
| 2023-06-30 | 4.3 million | - | 1.5 million |
| 2023-03-31 | 4.9 million | - | 1.6 million |
| 2022-12-31 | 7.4 million | - | 1.6 million |
BCDA Shares Outstanding
BCDA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 1.9 million | 1.1 million | - |
| 2023-06-30 | 2000 | 2.3 million | 1.2 million | - |
| 2023-03-31 | 10000 | 2.4 million | 1.2 million | - |
| 2022-12-31 | 2000 | 2.2 million | 924000 | - |
BCDA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 357000 | 104000 |
| 2023-06-30 | 43000 | 101000 |
| 2023-03-31 | 64000 | 101000 |
| 2022-12-31 | 106000 | 11.9 million |
BCDA
Price: $0.38
52 week price:
Earnings Per Share: -0.55 USD
P/E Ratio: -0.72
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 50500
Market Capitalization: 10.4 million